Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
10 papers
Recent·Most cited
I. Ullah, F. Escudie, I. Scandale, Z. Gilani, G. Gendron-Lepage, F. Gaudette, C. Mowbray, L. Fraisse, R. Bazin, A. Finzi, W. Mothes, P. Kumar, E. Chatelain, P. D. Uchil
This study evaluates DAAs and their combinations for SARS-CoV-2 clearance in mice, finding that dual-targeting regimens outperform monotherapies.
bioRxiv · May 31, 2023 · PreprintMicrobiology
I. Ullah, G. Beaudoin-Bussieres, K. Symmes, M. Cloutier, E. Ducas, A. Tauzin, A. Laumaea, P. Begin, W. Mothes, R. Bazin, A. Finzi, P. D. Uchil
This study shows that CCPs with high Fc-effector activity, rather than just neutralizing ability, are more effective in treating SARS-CoV-2 in mice.
bioRxiv · Jun 10, 2022Immunology
D. Chatterjee, A. Tauzin, L. Marchitto, S. Y. Gong, M. Boutin, C. Bourassa, G. Beaudoin-Bussieres, Y. Bo, S. Ding, A. Laumaea, D. Vezina, J. Perreault, L. Gokool, C. Morrisseau, P. Arlotto, , A. Finzi
This study evaluates how plasma from individuals with a 16-week interval between BNT162b2 mRNA vaccine doses recognizes and neutralizes the Omicron Spike compared to other variants.
bioRxiv · Dec 21, 2021Microbiology
S. P. Anand, J. Prevost, M. Nayrac, G. Beaudoin-Bussieres, M. Benlarbi, R. Gasser, N. Brassard, A. Laumaea, S. Y. Gong, C. Bourassa, E. Brunet-Ratnasingham, H. Medjahed, G. Gendron-Lepage, G. Goyette, L. Gokool, , A. Finzi
This study tracks humoral immune responses in convalescent individuals up to 8 months post-SARS-CoV-2 infection, showing that IgG+ memory B cells persist while plasma antibody levels decline.
bioRxiv · Jan 25, 2021Microbiology
S. P. Anand, J. Prevost, J. Richard, J. Perreault, T. Tremblay, M. Drouin, M.-J. Fournier, A. Lewin, R. Bazin, A. Finzi
This study tracks the decline of antibodies against the full-length SARS-CoV-2 Spike in convalescent plasma over time, showing a gradual decrease correlated with RBD-specific antibodies and days post-infection.
bioRxiv · Oct 20, 2020Microbiology
R. Gasser, M. Cloutier, J. Prevost, C. Fink, E. Ducas, S. Ding, N. Dussault, P. Landry, T. Tremblay, A. Laforce-Lavoie, A. Lewin, G. Beaudoin-Bussieres, A. Laumaea, H. Medjahed, C. Larochelle, , A. Finzi
This study shows that IgM plays a major role in neutralizing SARS-CoV-2 in convalescent plasma, with its depletion causing the greatest loss of neutralizing activity.
bioRxiv · Oct 9, 2020Microbiology
S. Ding, A. Laumaea, R. Gasser, H. Medjahed, M. Pancera, L. Stamatatos, A. McGuire, R. Bazin, A. Finzi
bioRxiv · Sep 8, 2020Microbiology
J. Perreault, T. Tremblay, M.-J. Fournier, M. Drouin, G. Beaudoin-Bussieres, J. Prevost, A. Lewin, P. Begin, A. Finzi, R. Bazin
The paper tracks antibody levels against SARS-CoV-2 RBD in convalescent plasma donors over time, finding a decline in antibodies after ~76 days post-symptoms onset.
bioRxiv · Jul 16, 2020 · PreprintImmunology
J. Prevost, R. Gasser, G. Beaudoin-Bussieres, J. Richard, R. Duerr, A. Laumaea, S. P. Anand, G. Goyette, M. Benlarbi, S. Ding, H. Medjahed, A. Lewin, J. Perreault, T. Tremblay, G. Gendron-Lepage, , A. Finzi
This study evaluates humoral responses against SARS-CoV-2 Spike in 106 infected individuals, finding persistent RBD-specific IgG and declining neutralizing activity over time.
bioRxiv · Jun 8, 2020Microbiology
G. Moquin-Beaudry, C. Colas, Y. Li, R. Bazin, J. V. Guimond, E. Haddad, C. Beausejour
This study shows that human umbilical cord mesenchymal stromal cells do not affect tumor growth or immune rejection in humanized mice.
bioRxiv · Jul 11, 2019Cell Biology